Phibro Animal Health reported $19.19M in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Align Technology ALGN:US $ 188.2M 9.89M
Ani Pharmaceuticals ANIP:US $ -12913000 6.28M
Aurora Cannabis Inc ACB:CN -996333000 932.06M
Bristol Myers Squibb BMY:US $ 2590M 37M
Canopy Growth Corp WEED:CN C$ -1838229000 1.3B
Corcept Therapeutics CORT:US $ 31.43M 4.66M
Depomed DEPO:US $ 10.79M 0.77M
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Henry Schein HSIC:US $ 220M 24M
Idexx Laboratories IDXX:US $ 179.07M 69.28M
Knight Therapeutics Inc GUD:CN C$ -39000 14.39M
Lannett LCI:US $ -22.08M 46M
Merk MRK:US $ 4927M 642M
Nektar Therapeutics NKTR:US $ -152.84M 36.28M
Pacira Pharmaceuticals PCRX:US $ 31.24M 13.84M
Phibro Animal Health PAHC:US $ 19.19M 3.1M
Prestige Brands PBH:US $ 87.01M 9.59M
Supernus Pharmaceuticals SUPN:US $ 11.35M 9.38M
Teva Pharmaceutical Industries TEVA:US $ -949M 236M
Zoetis ZTS:US $ 670M 57M